Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response
Temporal mass spectrometry proteomics, advanced microscopy, and in vivo modeling reveal nidogen-2 as a cotarget in PDAC.
Congratulations to @mbsanz.bsky.social MCR Paper of the Year 2024 Recipients, Brooke Pereira & Shona Ritchie, (co-led by @tcox.bsky.social ), for their latest work looking at the role of Nidogen-2 in pancreatic cancer published in Science Advances!
www.science.org/doi/10.1126/...
26.03.2025 22:20 — 👍 8 🔁 4 💬 0 📌 0
🥳 So happy to share I’ve been awarded a Cancer Institute NSW Fellowship! This will support my work on investigating metabolic perturbations in pancreatic cancer with the Timpson Lab
@garvaninstitute.bsky.social
@cancerecogarvan.bsky.social
20.03.2025 03:18 — 👍 10 🔁 1 💬 1 📌 0
Targeting the NPY/NPY1R signaling axis in mutant p53–dependent pancreatic cancer impairs metastasis
Targeting NPY1R reduces mutant p53–dependent pancreatic cancer metastasis.
Excited to kick off my Bluesky posting by sharing this work by the lab looking at the role of neuropeptideY in #pancreaticcancer metastasis. An amazing piece of work and so thrilled to see it finally out!
@garvaninstitute.bsky.social
www.science.org/doi/10.1126/...
14.03.2025 00:47 — 👍 5 🔁 1 💬 0 📌 0
The American Association for Cancer Research’s 10 peer-reviewed journals provide a renowned, respected forum for publishing the most innovative cancer science, encompassing the full spectrum of basic, translational, clinical, and epidemiological research.
Studying the cancer-cardiovascular disease interplay, with a focus on how cancer reprograms the hematopoietic and immune systems, at the Francis Crick Institute in London
http://www.adroverlab.com
Postdoc @ Garvan Institute | Epigenetics, development, evolution
Cell Identity + Cell Cycle Networks + Chromatin Dynamics & DevEvo in Human Development 🧬 @UNSWMedicine | #MyoTwitter 📝 @Prelights @PddcSydney #eLifeAmbassador
Our mission is to enable the promise of genomics to better human health by creating the world’s most advanced sequencing technologies.
Group Leader, Garvan Institute | Conjoint Lecturer, UNSW
Cytoskeletal and Oncogenic Signaling | Rare and Difficult-to-treat Diseases | Metastatic Disease | Immunodeficiencies
Art for Fun
We are a NCI funded consortium that is focused on understanding how to reprogram the stroma in pancreatic ductal adenocarcinoma (PDAC) in order to improve treatment responses and enhance survival. The coordinating center for PSRC is based at MD Anderson.
Imaging Immunologist
Cancer Researcher
@cruk-si.bsky.social
he/him
A world-class hub for research into cancer biotherapeutics.
We foster collaboration between scientists at King's College London, University College London, Barts Cancer Institute (QMUL) and The Francis Crick Institute.
https://www.colcc.ac.uk/
Research, news, and commentary from Nature, the international science journal. For daily science news, get Nature Briefing: https://go.nature.com/get-Nature-Briefing
Pancreatic cancer researcher at the CRUK Scotland Institute
Cancer researcher at Hunter College of the City University of New York & Weill Cornell Medicine. Views are my own.
The Victor Chang Cardiac Research Institute is dedicated to finding cures for heart disease through world-class medical research.
Sydney, Melbourne & Perth, Australia
www.victorchang.edu.au
Program Manager - Precision Immunology, Garvan Institute of Medical Research
Postdoc at Dana-Farber Cancer Institute / Harvard Medical School @Majzner Lab, working on T cell engineering for solid tumor immunotherpy, PhD @CRUK_SI @CoffeltLab. Interested in all things cancer immunotherapy. First gen
PhD student in @Timpson_Lab investigating the matrisome in pancreatic cancer @GarvanInstitute @UNSW
Cancer, Systems Biology and Drug Discovery Researcher | Laboratory Head - Garvan Institute | Assoc. Professor - UNSW
(very tired) Laboratory Head @wehi-research / cytokine biology gurus / gastrointestinal cancer fighters / views are our own
